Catalog name Description price
R-R-0317 (68Ga)Nota-prgd2 (68Ga)NOTA-PRGD2/CAS:1345968-02-6 is a radiolabeled compound used in molecular imaging and targeted therapy for cancer.In addition to its imaging applications, (68Ga)NOTA-PRGD2 can also be explored for targeted therapy. For example, therapeutic agents or radioisotopes can be attached to the peptide sequence, potentially allowing for the specific delivery of treatment to cancer cells expressing high levels of integrin receptors. price>
R-R-0369 cyclo(Arg-Gly-Asp-d-Phe-Glu) Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) (c(RGDfE))/Cas.756500-22-8 is a cyclic RGD peptide that serves as a conjugated multifunctional nanodrug delivery system to target Gemcitabine to pancreatic cancer cells. Cyclo(Arg-Gly-Asp-(D-Phe)-Glu) can be used in cancer research. price>
R-R-0628 Myelopeptide-2 (MP-2) Myelopeptide-2 is a peptide originally isolated from the supernatant of porcine bone marrow cell cultures, can restore mitogenic reactivity of human T lymphocytes inhibited by HL-60 leukemia cells or measles virus conditions. Myelopeptide-2 also recover depressed interleukin-2 (IL-2) synthesis and interleukin-2 receptor (IL-2R) expression. Myelopeptide-2 involves in immunity homeostasis, is perspective to be applied in antitumor and antivirus research. price>
R-R-0655 Simian Virus 40 Large Tumor Antigen Amino-Terminal Peptide The Simian Virus 40 (SV40) Large Tumor Antigen Amino-Terminal Peptide refers to a specific peptide derived from the SV40 virus, which has been extensively studied for its contributions to our understanding of molecular biology and cancer research. price>
R-R-0742 [D-Phe6,Leu-NHEt13,des-Met14]-Bombesin (6-14) (D-Phe6,Leu-NHEt13,des-Met14)-Bombesin (6-14)/CAS.124199-90-2 is a bombesin (BBN) antagonist and can be used for the research of cancer. price>
R-R-0744 [D-Phe12,Leu14]-Bombesin [D-Phe12,Leu14]-Bombesin/CAS.108437-88-3 is an antagonist of Bombesin Receptor.[D-Phe12,Leu14]-Bombesin can be used for the research of cancer. price>
R-R-0795 EMP-1 (Epithelial Membrane Protein) EMP-1 is identified as a surface biomarker whose expression correlates with acquisition of gefitinib resistance. EMP-1 expression is further correlated with lack of complete or partial response to gefitinib in lung cancer patient. price>
R-R-0820 Melanocyte Associated Antigen gp100 Melanocyte Associated Antigen gp100 is a protein that is expressed in melanocytes, which are the cells that produce the pigment melanin. The gp100 protein is also present in melanoma cells, a type of skin cancer. It plays a role in the melanin production process and is a target of immune responses in the context of melanoma.In cancer research and immunotherapy, gp100 has been studied as a potential target for cancer treatment, particularly in the development of cancer vaccines and immunotherapies aimed at activating the immune system to recognize and eliminate melanoma cells. price>
R-R-0821 Melanocyte Associated Antigen gp 100 (17 - 25) Melanocyte Associated Antigen gp 100 (17 - 25) indicates a specific segment of the Melanocyte Associated Antigen gp100 protein, specifically the sequence of amino acids 17 to 25 within the protein. This segment is the epitope derived from the gp100 protein that is recognized by T cells in the immune system. price>
R-R-0865 Plitidepsin Plitidepsin (Aplidine)/CAS.137219-37-5/ PM90001 is a potent anti-cancer agent by targeting eEF1A2 ( KD=80 nM). Plitidepsin possesses antiviral activity and is against SARS-CoV-2 with an IC90 of 0.88 nM. Plitidepsin is usually used for multiple myeloma and advanced cancer research, and has the potential for COVID-19 research. price>